Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Kyowa Kirin is a leading Japanese specialty biopharmaceutical company dedicated to the research, development, and marketing of innovative biopharmaceuticals. The company focuses on unmet medical needs, particularly in oncology, nephrology, immunology, and rare diseases, aiming to improve patient quality of life worldwide through scientific advancements.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Kyowa Kirin is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Kyowa Kirin last reported quarterly earnings on 8/3/2026 (Q2 2026). Earnings per share (EPS) came in at 35.49 JPY.
Across its last 4 earnings reports, Kyowa Kirin stock moved by ±1% on average the following day. The largest reaction was -2.1% on 10/29/2025; 0 of 4 reactions were positive.
Kyowa Kirin has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.